Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (181-190 of 299) with videos related to

Pageof 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomographyMalik E Juweid, Gregory A Wiseman, Julie M Vose, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
JCO Oncology Practice|September 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service LinesPaula M Fracasso, Nicole L Simone, Stephanie J Si Lim, et al.
British Journal of Haematology|March 5, 2003
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant RegistriesElisabeth Vandenberghe, Carmen Ruiz de Elvira, Fausto R Loberiza, et al.
Blood|December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphomaAlex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Human Pathology|November 25, 2017
Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphomaRadwa El Behery, Javier A Laurini, Dennis D Weisenburger, et al.
British Journal of Haematology|October 24, 2006
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett, Andrew M Evens, Leslie A Andritsos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow TransplantationMiguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
British Journal of Haematology|December 3, 2015
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trialRanjana H Advani, Stephen M Ansell, Mary J Lechowicz, et al.
Blood|December 8, 2009
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemiaJonathan W Friedberg, Jeff Sharman, John Sweetenham, et al.
Pageof 30

Showing results (181-190 of 299) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomographyMalik E Juweid, Gregory A Wiseman, Julie M Vose, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
JCO Oncology Practice|September 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service LinesPaula M Fracasso, Nicole L Simone, Stephanie J Si Lim, et al.
British Journal of Haematology|March 5, 2003
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant RegistriesElisabeth Vandenberghe, Carmen Ruiz de Elvira, Fausto R Loberiza, et al.
Blood|December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphomaAlex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Human Pathology|November 25, 2017
Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphomaRadwa El Behery, Javier A Laurini, Dennis D Weisenburger, et al.
British Journal of Haematology|October 24, 2006
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett, Andrew M Evens, Leslie A Andritsos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow TransplantationMiguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
British Journal of Haematology|December 3, 2015
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trialRanjana H Advani, Stephen M Ansell, Mary J Lechowicz, et al.
Blood|December 8, 2009
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemiaJonathan W Friedberg, Jeff Sharman, John Sweetenham, et al.
Pageof 30